COLLEGE OF MEDICINE AND HEALTH
Medicine, Nursing and Allied Health Professions

Loading content
Professor Marios Politis

Professor Marios Politis

Director of Mireille Gillings Neuroimaging Centre

 

Overview

Professor Marios Politis (MD MSc DIC PhD FRCP FEAN) is a Professor of Neurology, Consultant Neurologist, the Director of Neurodegeneration Imaging Group and the Director of Mireille Gillings Neuroimaging Centre at the University of Exeter.

Professor Marios Politis has receive a high number of awards for clinical, research, and clinical research excellence including a research achievement award by the MRC (2010), the Movement Disorder Society Award for Outstanding and Innovative Clinical Research (2012), the IMPETus award for innovative and outstanding PET molecular imaging research (2013, 2014, 2015, 2016) and the PET Investigator Award from the Society of Nuclear Medicine and Molecular Imaging (2015). In 2016, he was elected Fellow of the European Academy of Neurology for outstanding contribution in neurodegenerative research. In 2017, he received the Jon Stolk Award in Movement Disorders from the American Academy of Neurology and was elected Fellow of Royal College of Physicians.

Professor Marios Politis has significant industry experience by serving as a clinical investigator, consultant and principal investigator in several collaborations with industrial partners and pharma including a number of clinical trials. He has trained over 120 clinical and non-clinical fellows, research associates and research assistants, and undergraduate and postgraduate students at NIG. He has raised a record amount of over £60 million for cutting-edge research in neurodegenerative conditions such as Parkinson’s disease, Alzheimer’s disease and other neurodegenerative disorders; and is actively collaborating with a high number of philanthropic, government, non-commercial and commercial industrial partners.  Professor Marios Politis has published over 150 high impact papers and has been running a specialist Neurology and Movement Disorder clinical service for over 15 years with previous appointments at UCLH, Hammersmith and Charring Cross Hospitals, and King’s College Hospital. He has currently clinical Consultant contracts with the Royal Devon and Exeter NHS Foundation Trust and the Imperial College Healthcare NHS Trust. 

Qualifications

  • 2004 – University of Athens, MD
  • 2007 – Imperial College London, MSc
  • 2010 – Imperial College London, PhD
  • 2016 – Fellow of European Academy of Neurology
  • 2017 – Fellow of Royal College of Physicians

Research

Research interests

Professor Marios Politis research involves the use of Positron Emission Tomography (PET) and Single Photon Emission Tomography (SPECT) molecular imaging, structural and functional Magnetic Resonance Imaging (MRI), CSF and blood molecular markers, digital markers and clinical observation as methods of investigating aetiology, pathophysiology, and effects and complications of novel therapies in Neurodegenerative disorders.

Publications

Key publications | Publications by category | Publications by year

Publications by category


Journal articles

Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, et al (2020). Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. The Lancet Neurology, 19(1), 71-80. Abstract.
Carotenuto A, Wilson H, Giordano B, Caminiti SP, Chappell Z, Williams SCR, Hammers A, Silber E, Brex P, Politis M, et al (2020). Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications. Journal of Neurology, 267(7), 2042-2053. Full text.

Publications by year


2020

Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, et al (2020). Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. The Lancet Neurology, 19(1), 71-80. Abstract.
Carotenuto A, Wilson H, Giordano B, Caminiti SP, Chappell Z, Williams SCR, Hammers A, Silber E, Brex P, Politis M, et al (2020). Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications. Journal of Neurology, 267(7), 2042-2053. Full text.

Marios_Politis Details from cache as at 2020-07-09 05:31:44

Refresh publications

Teaching

Supervision / Group

Back | Edit Profile